| Description: | RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor. PURPOSE: This phase III trial is studying everolimus to see how well it works in treating patients with kidney cancer who have undergone surgery. |
|---|
| Link: | http://clinicaltrials.gov/ct2/show/study/NCT01120249 |
|---|---|
| Site: | Associates in Oncology and Hematology |
| Principal Investigator: | Paul M. Thambi |